Role for PET Imaging in Reducing Tx Toxicity in Advanced Hodgkin Lymphoma?

Final data from a phase III trial, presented at the 2018 Congress of the European Hematology Association, demonstrate that performing PET scan after two cycles of up-front escalated BEACOPP in patients with advanced Hodgkin lymphoma may identify early-responding patients who could be de-escalated, resulting in reduced treatment-related toxicity without affecting treatment outcome.

Cancer Network